Home

Insights

PE

Sanjivani Paranteral Ltd P/E Ratio

Sanjivani Paranteral Ltd P/E Ratio

download
stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

16.0 K

stocks traded

Last Updated time: 13 Jul 15:30 PM

Image

Sanjivani Paranteral Ltd

NSE: SANJIVPARANT

PE

39.7

Last updated : 13 Jul 15:30 PM

Key Highlights

    The P/E Ratio of Sanjivani Paranteral Ltd is 39.7 as of 13 Jul 15:30 PM .a1#The P/E Ratio of Sanjivani Paranteral Ltd changed from 6.6 on March 2019 to 9.2 on March 2023 . This represents a CAGR of 11.71% over 3 years. a1#The Latest Trading Price of Sanjivani Paranteral Ltd is ₹ 209.65 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Pharmaceuticals industry is 37.5. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Sanjivani Paranteral Ltd changed from ₹ 2.85 crore on March 2019 to ₹ 41.42 crore on March 2023 . This represents a CAGR of 70.79% over 5 years. a1#The Revenue of Sanjivani Paranteral Ltd changed from ₹ 10.03 crore to ₹ 12.92 crore over 8 quarters. This represents a CAGR of 13.50% a1#The EBITDA of Sanjivani Paranteral Ltd changed from ₹ 2.27 crore to ₹ 2.21 crore over 8 quarters. This represents a CAGR of -1.33% a1#The Net Pr of Sanjivani Paranteral Ltd changed from ₹ 1.8 crore to ₹ 1.26 crore over 8 quarters. This represents a CAGR of -16.33% a1#The Dividend Payout of Sanjivani Paranteral Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Sanjivani Paranteral Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Sanjivani Paranteral Ltd

Period
Mar '190
Mar '200
Mar '216.6
Mar '2213.5
Mar '239.2

Company Fundamentals for Sanjivani Paranteral Ltd

Market Cap

244 Cr

EPS

5.3

P/E Ratio (TTM) *

39.7

P/B Ratio (TTM) *

8.8

Day’s High

219.0

Day’s Low

203.6

DTE *

0.0

ROE *

22.1

52 Week High

232.85

52 Week Low

62.0

ROCE *

27.1

* All values are consolidated

Last Updated time: 13 Jul 15:30 PM

* All values are consolidated

Last Updated time: 13 Jul 15:30 PM

Image

Sanjivani Paranteral Ltd

NSE: SANJIVPARANT

PRICE

209.65

-0.20 (-0.10%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Sanjivani Paranteral Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Sanjivani Paranteral Ltd

Market Value

245

Asset Value

9

27.6 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Sanjivani Paranteral Ltd39244
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of Sanjivani Paranteral Ltd

Earnings

6 Cr

39.7 X

PE Ratio

Market Cap

₹244.96Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

6 Cr

39.7 X

PE Ratio

Market Cap

₹244.96Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Sanjivani Paranteral Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Sanjivani Paranteral Ltd

Period
Mar '193
Mar '205
Mar '219
Mar '2265
Mar '2341

* All values are a in crore

×

Historical Revenue of Sanjivani Paranteral Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Sanjivani Paranteral Ltd

Period
Jun '2210
Sep '229
Dec '229
Mar '238
Jun '2313
Sep '2314
Dec '2315
Mar '2413

* All values are a in crore

×

Historical EBITDA of Sanjivani Paranteral Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Sanjivani Paranteral Ltd

Period
Jun '222
Sep '221
Dec '221
Mar '231
Jun '232
Sep '232
Dec '232
Mar '242

* All values are a in crore

×

Historical Net Profit of Sanjivani Paranteral Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Sanjivani Paranteral Ltd

Period
Jun '222
Sep '221
Dec '221
Mar '231
Jun '232
Sep '232
Dec '232
Mar '241

* All values are a in crore

×

Historical Dividend Payout of Sanjivani Paranteral Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Sanjivani Paranteral Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Sanjivani Paranteral Ltd

About Sanjivani Paranteral Ltd

    Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.'94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Company's products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.'96 to part-finance the project. The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year' production of liquid vials and ampules. During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa, Europe & Latin America. The Company has also tied up with Cadila Ltd., Alkem Ltd., Indian Immunologicals Ltd for marketing its products. During the year 1999-2000, the company has tied-up with India's first ranked pharmaceutical giant Ranbaxy for manufacturing its products. During 2009, the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand.

Sanjivani Paranteral Ltd News Hub

News

Sanjivani Paranteral to convene board meeting

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 13 Ma...

Read more

07 May 202411:48

News

Sanjivani Paranteral to conduct board meeting

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 8 Apr...

Read more

03 Apr 202409:57

News

Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 5 Feb...

Read more

25 Jan 202417:14

News

Sanjivani Paranteral to convene EGM

Sanjivani Paranteral announced that an Extra Ordinary General Meeting (EGM) of the Company...

Read more

26 Dec 202315:58

News

Sanjivani Paranteral to convene board meeting

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 25 De...

Read more

20 Dec 202310:22

News

Sanjivani Paranteral to announce Quarterly Result

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 18 Oc...

Read more

12 Oct 202310:21

Product Composition by Percentage (Revenue)

FAQs for PE of Sanjivani Paranteral Ltd

What is Sanjivani Paranteral Ltd current share price?

The current market price of Sanjivani Paranteral Ltd as of July 13, 2024 is ₹209.65.

What is Sanjivani Paranteral Ltd's market cap?

Sanjivani Paranteral Ltd's market capitalisation stood at ₹244 Cr as of July 13, 2024

What are Sanjivani Paranteral Ltd's total net assets?

According to Sanjivani Paranteral Ltd's most recent financial filings, the company's net assets total ₹8.6 Cr.

Is Sanjivani Paranteral Ltd making a profit or loss?

Sanjivani Paranteral Ltd's net Profit as of July 13, 2024 is close to ₹6 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199